Plasma leukaemia inhibitory factor, interleukin 6 and soluble interleukin 6 receptor levels during cardiopulmonary bypass with extracorporeal circulation

被引:21
作者
Denizot, Y
Lorgeot, V
Cornu, E
Nathan, N
机构
[1] CHRU Dupuytren, Dept Anesthesie, F-87042 Limoges, France
[2] CHRU Dupuytren, Dept Chirurg Cardiovasc, F-87042 Limoges, France
关键词
cardiopulmonary bypass; CEC; IL-6; LIF; soluble IL-6 receptor;
D O I
10.1006/cyto.1997.0285
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study the authors assessed plasma leukaemia inhibitory factor (LIF), interleukin 6 (IL-6) and soluble IL-6 receptor (sIL-6R) concentrations in 28 patients undergoing coronary artery bypass graft (CABG) with extracorporeal circulation (ECC), Plasma IL-6 levels increased during ECC, reaching a 33-fold increase 6 h after surgery as compared to pre-operative values. In contrast, plasma sIL-6R and LIF concentrations did not vary significantly during cardiac surgery. Thus, LIF is not implicated in the haematological changes and in the inflammatory syndrome observed after CABG. Despite the fact that LIF and IL-6 exhibit several common biological activities, the production of these two cytokines is differently regulated during cardiac surgery with ECC, Plasma IL-6 levels increased during cardiac surgery while sIL-6R levels did not changed, These data contrast with the decreased sIL-6R concentrations with concomitantly high IL-6 levels in patients with sepsis syndrome suggesting that inflammatory reactions in sepsis and after cardiopulmonary bypass are triggered by different mechanisms. (C) 1998 Academic Press Limited.
引用
收藏
页码:303 / 306
页数:4
相关论文
共 23 条
  • [1] BAUMANN H, 1989, J IMMUNOL, V143, P1163
  • [2] INFLAMMATORY RESPONSE TO CARDIOPULMONARY BYPASS
    BUTLER, J
    ROCKER, GM
    WESTABY, S
    [J]. ANNALS OF THORACIC SURGERY, 1993, 55 (02) : 552 - 559
  • [3] ROLE OF CYTOKINES IN THE PATHOGENESIS OF CARDIOPULMONARY-INDUCED MULTISYSTEM ORGAN FAILURE
    CASEY, LC
    [J]. ANNALS OF THORACIC SURGERY, 1993, 56 (05) : S92 - S96
  • [4] Plasma macrophage colony-stimulating factor levels during cardiopulmonary bypass with extracorporeal circulation
    Denizot, Y
    Fixe, P
    Cornu, E
    Nathan, N
    [J]. MEDIATORS OF INFLAMMATION, 1996, 5 (05) : 358 - 361
  • [5] Serum interleukin-8 (IL-8) and IL-6 concentrations in patients with hematologic malignancies
    Denizot, Y
    Fixe, P
    Liozon, E
    Praloran, V
    [J]. BLOOD, 1996, 87 (09) : 4016 - 4017
  • [6] Development of enzymo-immunoassays (EIA) for macrophage colony-stimulating factor (M-CSF) and leukaemia inhibitory factor (LIF) by using the same capture and signal generating polyclonal antibody
    Fixe, P
    Lorgeot, V
    LeMeur, Y
    Coupey, L
    Heymann, D
    Godard, A
    Praloran, V
    [J]. CYTOKINE, 1996, 8 (07) : 586 - 591
  • [7] CIRCULATING INTERLEUKIN-6 RECEPTOR IN PATIENTS WITH SEPSIS SYNDROME
    FRIELING, JTM
    VANDEUREN, M
    WIJDENES, J
    VANDERMEER, JWM
    CLEMENT, C
    VANDERLINDEN, CJ
    SAUERWEIN, RW
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (02) : 469 - 472
  • [8] SOLUBLE INTERLEUKIN-6 RECEPTOR STRONGLY INCREASES THE PRODUCTION OF ACUTE-PHASE PROTEIN BY HEPATOMA-CELLS BUT EXERTS MINIMAL CHANGES ON HUMAN PRIMARY HEPATOCYTES
    GABAY, C
    SILACCI, P
    GENIN, B
    MENTHA, G
    LECOULTRE, C
    GUERNE, PA
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (08) : 2378 - 2383
  • [9] INCREASED AND HIGHLY STABLE LEVELS OF FUNCTIONAL SOLUBLE INTERLEUKIN-6 RECEPTOR IN SERA OF PATIENTS WITH MONOCLONAL GAMMOPATHY
    GAILLARD, JP
    BATAILLE, R
    BRAILLY, H
    ZUBER, C
    YASUKAWA, K
    ATTAL, M
    MARUO, N
    TAGA, T
    KISHIMOTO, T
    KLEIN, B
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (04) : 820 - 824
  • [10] LEUKEMIA INHIBITORY FACTOR RECEPTOR IS STRUCTURALLY RELATED TO THE IL-6 SIGNAL TRANSDUCER, GP130
    GEARING, DP
    THUT, CJ
    VANDENBOS, T
    GIMPEL, SD
    DELANEY, PB
    KING, J
    PRICE, V
    COSMAN, D
    BECKMANN, MP
    [J]. EMBO JOURNAL, 1991, 10 (10) : 2839 - 2848